Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma
Clinical trial NCT05080790 · COMPLETED
Trial details
- NCT number
- NCT05080790
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2025-01-20
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.